In the future trend, generative artificial intelligence will bring exponential growth to AI medical imaging companies, and the combination of comprehensive medical artificial intelligence models and medical imaging fields will release great potential. Therefore, AI medical imaging companies will rely on ecological routes to accelerate their own hematopoietic speed and improve their ability to commercialize.
Chinese intelligent medical imaging market environment analysis
Due to the aging environment, uneven distribution of medical resources, and large gaps in the field of medical imaging, medical radiologists bear greater medical pressure
According to epidemiological data surveys, the prevalence of chronic diseases in the elderly was 62.3% in 2018, compared with 46.8% in 2008, an increase of 15.5% in ten years. At the same time, due to the uneven distribution of medical resources, a large number of patients still pour into tertiary hospitals, which brings a great burden to the work of radiologists in tertiary hospitals.
According to statistics, the current annual growth rate of medical imaging data in mainland China is 30%, while the annual growth rate of radiologists is only 4%, and taking CT reports as an example, radiologists need to complete 80-100 readings per day, in general, simple CT image readings may only take a few minutes, while complex cases may take longer, may take 30 minutes or more. Medical radiologists face greater work pressure.
The policy supports the development of domestic medical imaging equipment and artificial intelligence applications to solve the shortage of medical resources
According to the medical imaging related policies issued by various government departments in 2022-2023, it can be seen that the policy vigorously promotes the development of domestic medical imaging equipment and actively explores multiple application scenarios of artificial intelligence in medical imaging to solve the problem of shortage of medical resources.
At the same time, policy support is provided for the development of artificial intelligence medical imaging, that is, image database and artificial intelligence algorithm.
The construction of digital image cloud in various provinces has laid a good foundation for grassroots remote film reading and the application of AI medical imaging products
At present, many provinces have provided digital imaging services, and patients can choose to store their image results on the image cloud and pay an amount of about 20 yuan. The application of imaging cloud services provides a good foundation for remote reading, and the use of AI medical imaging products at the reading terminal can effectively reduce the missed diagnosis rate and help radiologists reduce the burden.
70 AI medical imaging products have obtained three types of certificates, covering 13 types
As of July 5, 2023, the NMPA has approved a total of 70 three-category certificates, covering two categories: auxiliary diagnosis and auxiliary treatment from the diagnosis and treatment process, among which auxiliary diagnosis includes coronary arteries, lung nodules, fractures/bone age, and fundus; Adjuvant therapy mainly includes products related to radiation therapy.
The application of AI medical imaging extends to the breadth of diagnosis and clinical depth at the same time
According to the data, as of July 2023, a total of 13 AI+ coronary products and 6 AI+ intracranial/head and neck products have obtained three types of certificates, and the certification speed in the past two years is higher than that of other parts.
From 2022 to 2023, AI+ radiotherapy products will be certified centrally, and AI medical imaging application scenarios will extend to treatment. As of July 2023, a total of 6 products have obtained Class III certification, including 2 radiotherapy contouring software and 4 radiotherapy planning software.
From 2020 to 2023, fracture/bone age products have been intensively certified, and their auxiliary value for primary medical internal examination and testing has been basically verified.
From 2022 to 2023, a total of 4 AI+ endoscope products will be intensively certified. The application of artificial intelligence medical image-assisted detection has been expanded. The value of AI technology in the capture and application of lesions in real-time dynamic medical imaging has been verified.
Although it is intensively certified, the product application has a lot of room for improvement. At the same time, the supervision of AI medical imaging algorithms is gradually complete
In 2020, the first batch of artificial intelligence medical device industry standards in mainland China, "Quality Requirements and Evaluation of Artificial Intelligence Medical Devices Part 1: Terminology" and "Quality Requirements and Evaluation of Artificial Intelligence Medical Devices Part 2: General Requirements for Data Sets" have entered the approval stage, and subsequent industry standards are still being introduced.
According to the survey data of the hospital imaging department in 2022, radiologists believe that the biggest problem in the current AI medical imaging products is that there are few products that can be actually applied. The integration of AI technology and medical imaging has greater potential, and there is still a lot of room for development in reducing doctors' work pressure, improving work efficiency and breaking through medical problems, so Yiou believes that AI medical imaging software has more room for product optimization.
As a result, the artificial intelligence medical imaging industry has developed to the stage of product optimization
The market size of artificial intelligence medical imaging is expected to be 2.4 billion yuan in 2023
Artificial intelligence medical application scenarios are extensive, and with the increase in the number of certified products, the overall market scale has begun to appear. At this stage, AI medical imaging has commercial landing products in hospitals, outside hospitals and overseas channels, and with the gradual establishment of ecological routes, the scale of AI medical imaging market will usher in rapid growth in the future. Yiou believes that the AI medical imaging market size will be 2.4 billion yuan in 2023 and will reach 13.74 billion yuan in 2030, with a compound annual growth rate of 33.8%.
Life cycle assessment methodology of Chinese intelligent medical imaging products
SCCE model of AI medical imaging product life cycle
At present, medical artificial intelligence led by AI medical imaging has entered the global and Chinese changes have occurred, and the types of products have been listed in a group, referring to the cases of innovative drugs or generic drugs, intensive R&D and listing make enterprises not necessarily obtain good income expectations. Whether the R&D investment of enterprises can be recovered and profitable in a limited time has become its core issue. Product life cycle management will become the key to the success or failure of enterprises, rational, prudent and comprehensive evaluation of the future market space of a product, which will help enterprises avoid waste of time and money.
The following is an excerpt from the text of the report: